Co-Diagnostics (FRA:C97) ROE % Adjusted to Book Value : -93.38% (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Co-Diagnostics ROE % Adjusted to Book Value?

Co-Diagnostics's ROE % for the quarter that ended in Sep. 2024 was -56.03%. Co-Diagnostics's PB Ratio for the quarter that ended in Sep. 2024 was 0.60. Co-Diagnostics's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -93.38%.

Co-Diagnostics ROE % Adjusted to Book Value Historical Data

The historical data trend for Co-Diagnostics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Co-Diagnostics ROE % Adjusted to Book Value Chart

Co-Diagnostics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-198.49

28.15

16.74

-17.67

-65.40

Co-Diagnostics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-72.00	-118.04	-103.18	-72.38	-93.38

Competitive Comparison of Co-Diagnostics's ROE % Adjusted to Book Value

For the Medical Devices subindustry, Co-Diagnostics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Co-Diagnostics's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Co-Diagnostics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Co-Diagnostics's ROE % Adjusted to Book Value falls into.

Save

Co-Diagnostics ROE % Adjusted to Book Value Calculation

Co-Diagnostics's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-34.66%	/	0.53
	=	-65.40%

Co-Diagnostics's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-56.03%	/	0.60
	=	-93.38%

Co-Diagnostics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Co-Diagnostics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Co-Diagnostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Co-Diagnostics Inc (FRA:C97) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

CODX:USA 0A50:UK

Address

2401 South Foothill Drive, Salt Lake City, UT, USA, 84109

Website

https://www.codiagnostics.com

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Co-Diagnostics Headlines

No Headlines